MedPath

NNC0638-0355

Generic Name
NNC0638-0355

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Research Report

Published: Jun 5, 2025

Morphine: A Comprehensive Pharmacological and Clinical Review

I. Introduction to Morphine

A. Overview and Significance

Morphine, the principal alkaloid of opium, stands as a cornerstone in the history of pharmacology and pain management. First isolated in 1805, it is a potent opioid agonist primarily utilized for the relief of moderate to severe acute and chronic pain.[1] Its profound analgesic properties have made it an indispensable tool in medicine for over two centuries. However, the therapeutic utility of morphine is significantly constrained by the development of tolerance, the occurrence of a distressing withdrawal syndrome upon cessation, and a substantial risk of abuse and addiction.[4] Despite these considerable limitations, morphine continues to be a routinely employed analgesic worldwide, often serving as a benchmark against which other opioids are compared. It exists alongside a diverse array of semi-synthetic and synthetic opioids, many of which were developed in attempts to capture morphine's analgesic efficacy while minimizing its undesirable characteristics.[6] The dual nature of morphine—as both an essential medicine and a substance with a high liability for dependence—has profoundly shaped its medical application, societal perception, and the stringent regulatory frameworks governing its use.

Continue reading the full research report

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.